CardioComm Solutions 

$0.010000
2
-$0.00-8.26% Tuesday 16:03

統計

當日最高
0.01
當日最低
0.01
52週高點
0.011
52週低點
0.004
成交量
60,000
平均成交量
1,302
市值
1.98M
本益比
0
股息殖利率
-
股息
-

財報

30Sep預期
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0
-0
0
0
預期EPS
不適用
實際EPS
-0.0003

財務

-196.92%利潤率
未盈利
2020
2021
2022
2023
2024
2025
194,826.29營收
-383,658.04淨利

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

CardioComm Solutions, Inc., established in 1989 and based in Toronto, Canada, specializes in developing advanced technological solutions for cardiac monitoring. The company delivers both sophisticated software and hardware products, as well as core laboratory reading services, specifically designed for electrocardiogram (ECG) and ambulatory arrhythmia detection systems. These comprehensive offerings cater to both the medical sector and individual consumers across the globe. At the heart of CardioComm's operations is proprietary technology that underpins the entire ECG workflow: from initial recording and seamless transmission to detailed viewing, in-depth analysis, comprehensive reporting, and secure long-term storage. This end-to-end capability is crucial for the effective screening, accurate diagnosis, and ongoing management of cardiac patients. Their unique device connectivity and ECG management platforms are integrated into diverse solutions, spanning general medical applications, consumer-grade health products, clinical research initiatives, and modern telemedicine services. The company's extensive software suite includes the Global ECG Management System (GEMS) for cardiac event monitoring, GlobalCardio 12 Lead—a web-enabled and EMR-compatible ECG device—and GEMS Lite for Windows, an electronic system for receiving ECG data. Complementary software modules further enhance their offerings, such as GEMS WIN Air for live wireless ECG monitoring, AutoAttendant to empower healthcare providers by automating routine tasks, and the GEMS HL7 Interface, which ensures compliant data exchange with other EMR systems. Additionally, GlobalCardio EMR integration facilitates the bi-directional transfer of crucial information, including patient data, reports, and related links. Beyond software, CardioComm provides a range of hardware products. These include the portable HeartCheck PEN and HeartCheck handheld ECG monitors, various Sirona telephonic and wireless event recorders, and the HeartCheck CardiBeat device. Furthermore, the company offers Application Service Provider (ASP) solutions, notably C4 ECG management services and HeartCheck SMART Monitoring. Their broader product portfolio also features GlobalCardio 3 Lead, the ECG Viewer SDK, QRS Diagnostic, and QRS 12 Lead Universal.
Show more...
執行長
Etienne Grima
員工
16
國家
加拿大
ISIN
CA14159N2086

上市

0 Comments

分享你的想法

FAQ

CardioComm Solutions 今天的股價是多少?
EKGGF 目前價格為 $0.01 USD,過去 24 小時下跌了 -8.26%。在圖表上更密切關注 CardioComm Solutions 股票的表現。
CardioComm Solutions 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 OTC Link 交易所,CardioComm Solutions 的股票以代號 EKGGF 進行交易。
CardioComm Solutions 的股價在上漲嗎?
EKGGF 股票較上週上漲 +0%,本月下跌 -8.26%,過去一年 CardioComm Solutions 上漲 +150%。
CardioComm Solutions 的市值是多少?
今天 CardioComm Solutions 的市值為 1.98M
CardioComm Solutions 上一季度的財報如何?
EKGGF 上一季度的財報為每股 -0 USD,預估為 不適用 USD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 USD。
CardioComm Solutions 去年的營收是多少?
CardioComm Solutions 去年的營收為 194,826.29USD。
CardioComm Solutions 去年的淨利是多少?
EKGGF 去年的淨收益為 -383,658.04USD。
CardioComm Solutions 有多少名員工?
截至 September 05, 2026,公司共有 16 名員工。
CardioComm Solutions 位於哪個產業?
CardioComm Solutions從事於Health & Wellness產業。
CardioComm Solutions 何時完成拆股?
CardioComm Solutions 上次拆股發生於 November 28, 2007,比例為 1:5。
CardioComm Solutions 的總部在哪裡?
CardioComm Solutions 的總部位於 加拿大 的 Toronto。